Type 1 Diabetes Mellitus Clinical Trials

53 recruiting

Frequently Asked Questions

Common questions about Type 1 Diabetes Mellitus clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 66 trials

Recruiting

Biomarkers of Acute Organ Injury in Pediatric Newly Diagnosed Type 1 Diabetes

Type 1 Diabetes MellitusDiabetic Ketoacidosis
Aristotle University Of Thessaloniki45 enrolled1 locationNCT07483879
Recruiting
Not Applicable

Physical Activity to Prevent and Treat Hyperglycemia From a Mistimed Bolus Insulin Dose

Type 1 Diabetes Mellitus
Jane Yardley30 enrolled1 locationNCT06686329
Recruiting
Not Applicable

Clinical Study to Evaluate the Impact of the Accu-Chek SmartGuide CGM Solution on the Mean Change in Time in Range Compared With Self-Monitoring of Blood Glucose in Participants With Type 1 and Type 2 Diabetes Mellitus

Type 1 Diabetes MellitusType 2 Diabetes Mellitus
Hoffmann-La Roche270 enrolled14 locationsNCT06704672
Recruiting

Establishment of Screening Pathway for High-Risk Population of Type 1 Diabetes

Type 1 Diabetes Mellitus
Peking University First Hospital340 enrolled1 locationNCT07468474
Recruiting
Phase 1Phase 2

CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)

Type 1 DiabetesType 1 Diabetes MellitusType 1 Diabetes Mellitis+7 more
COUR Pharmaceutical Development Company, Inc.72 enrolled31 locationsNCT06783309
Recruiting

Characterization of Type 1 Diabetes Subgroup: An Artificial Intelligence Analysis of Clinical and Glucometric Features

Type 1 Diabetes Mellitus
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau800 enrolled1 locationNCT07461805
Recruiting

Type 1 Diabetes Extension Study

Type 1 Diabetes MellitusT1DT1DM
National Institute of Allergy and Infectious Diseases (NIAID)111 enrolled12 locationsNCT02734277
Recruiting
Phase 3

A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes

Type 1 Diabetes Mellitus
Sanofi723 enrolled107 locationsNCT07088068
Recruiting
Phase 1Phase 2

Safety, Tolerability, and Efficacy of Immunomodulation With A Monoclonal Antibody Against CD40L in Combination With Transplanted Islet Cells in Adults With Brittle Type 1 Diabetes Mellitus (T1D)

Type 1 Diabetes Mellitus
University of Chicago70 enrolled1 locationNCT06305286
Recruiting
Not Applicable

Continuous Glucose Monitoring for Outpatient Diabetes Management After Hospital Discharge

Type 1 Diabetes Mellitus (T1DM)Type 2 Diabetes Mellitus (T2DM)Hyperglycemia
Vanderbilt University Medical Center60 enrolled1 locationNCT06852950
Recruiting
Phase 1Phase 2

A Study to Investigate Safety and Effectiveness of Porcine Pancreatic Cells (OPF-310) in Patients With Type 1 Diabetes Mellitus

Metabolic DiseaseDiabetes Mellitus, Type 1Type 1 Diabetes+14 more
Otsuka Pharmaceutical Factory, Inc.13 enrolled1 locationNCT06575426
Recruiting

Evaluation of Oxidative Stress: Comparison Between Type 1 Diabetes Mellitus and Latent Autoimmune Diabetes in Adults

Type 1 Diabetes MellitusLatent Autoimmune Diabetes in Adult (LADA)
Fondazione IRCCS Policlinico San Matteo di Pavia75 enrolled1 locationNCT07434154
Recruiting
Phase 2

FrexalimAB in Preservation of Endogenous insULIN Secretion Compared to Placebo in adUlts and Adolescents on Top of inSulin Therapy (FABULINUS)

Type 1 Diabetes Mellitus
Sanofi192 enrolled80 locationsNCT06111586
Recruiting
Not Applicable

Accuracy and Precision of the Continuous Glucose Monitoring System 'CareSens Air 3' in Adult Patients With T1DM

Type 1 Diabetes Mellitus
i-SENS, Inc.32 enrolled4 locationsNCT07296276
Recruiting
Not Applicable

GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes

Type 1 Diabetes MellitusType 2 Diabetes Mellitus
Medtronic Diabetes400 enrolled33 locationsNCT07228117
Recruiting
Phase 4

A Multicenter, Prospective, Controlled Clinical Trial Evaluating the Efficacy of a Single Layer Placental-based Allograft and Standard of Care in the Management of Nonhealing Diabetic Foot Ulcers

Diabetic Foot UlcerDiabetic FootFoot Ulcer Due to Type 2 Diabetes Mellitus+4 more
Applied Biologics, LLC60 enrolled1 locationNCT07159282
Recruiting
Phase 1

A Study of GNTI-122 in Adults Recently Diagnosed With T1D

Type 1 Diabetes MellitusType 1 Diabetes (T1D)
GentiBio, Inc16 enrolled10 locationsNCT06919354
Recruiting
Not Applicable

Gamification Intervertion in Children With Type 1 Diabetes

Type 1 Diabetes Mellitus
KTO Karatay University52 enrolled1 locationNCT07409701
Recruiting
Phase 2

INHALE-1st: Afrezza® For Youth With Newly-Diagnosed Type 1 Diabetes

Type 1 Diabetes Mellitus
Mannkind Corporation100 enrolled2 locationsNCT07224321
Recruiting

The MICRON Study - A Steno 1 Substudy

Type 1 Diabetes Mellitus
University of Aarhus40 enrolled5 locationsNCT07270172